Surgery Partners Stock Has 26% Upside to Mean Analyst Target

Zacks Investment Research··Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Surgery Partners shares closed at $14.23 and could rise 26.1% to a mean analyst price target of $17.95, based on 11 short-term estimates. The targets range from $14.00 to $24.00, with a standard deviation of $2.90. Analysts have also raised the current-year consensus earnings estimate by 44.1% over the past 30 days, and the stock carries a Zacks Rank #1 (Strong Buy).

Impact on assets 1

Health Care▲
Surgery Partners Inc
SGRY
▲ PositiveCapitalrelevance

Analyst price target implies 26% upside, and earnings estimates raised 44% over 30 days.